Orthofix Medical Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $12.93
- Today's High:
- $15.32
- Open Price:
- $14.61
- 52W Low:
- $12.93
- 52W High:
- $23.19
- Prev. Close:
- $18.63
- Volume:
- 5522097
Company Statistics
- Market Cap.:
- $684.44 million
- Book Value:
- 17.423
- Revenue TTM:
- $598.44 million
- Operating Margin TTM:
- -11.57%
- Gross Profit TTM:
- $337.17 million
- Profit Margin:
- -19.74%
- Return on Assets TTM:
- -6.35%
- Return on Equity TTM:
- -24.06%
Company Profile
Orthofix Medical Inc had its IPO on 1992-04-24 under the ticker symbol OFIX.
The company operates in the Healthcare sector and Medical Devices industry. Orthofix Medical Inc has a staff strength of 1,092 employees.
Stock update
Shares of Orthofix Medical Inc opened at $14.61 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $12.93 - $15.32, and closed at $13.01.
This is a -30.17% slip from the previous day's closing price.
A total volume of 5,522,097 shares were traded at the close of the day’s session.
In the last one week, shares of Orthofix Medical Inc have slipped by -38.86%.
Orthofix Medical Inc's Key Ratios
Orthofix Medical Inc has a market cap of $684.44 million, indicating a price to book ratio of 1.2204 and a price to sales ratio of 0.8815.
In the last 12-months Orthofix Medical Inc’s revenue was $598.44 million with a gross profit of $337.17 million and an EBITDA of $-23467000. The EBITDA ratio measures Orthofix Medical Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Orthofix Medical Inc’s operating margin was -11.57% while its return on assets stood at -6.35% with a return of equity of -24.06%.
In Q2, Orthofix Medical Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 58.4%.
Orthofix Medical Inc’s PE and PEG Ratio
- Forward PE
- 60.241
- Trailing PE
- 0
- PEG
- 4.1
Its diluted EPS in the last 12-months stands at $-3.57 per share while it has a forward price to earnings multiple of 60.241 and a PEG multiple of 4.1. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Orthofix Medical Inc’s profitability.
Orthofix Medical Inc stock is trading at a EV to sales ratio of 0.8099 and a EV to EBITDA ratio of 28.0416. Its price to sales ratio in the trailing 12-months stood at 0.8815.
Orthofix Medical Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $901.29 million
- Total Liabilities
- $141.80 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $12.82 million
- Dividend Payout Ratio
- 0%
Orthofix Medical Inc ended 2024 with $901.29 million in total assets and $0 in total liabilities. Its intangible assets were valued at $901.29 million while shareholder equity stood at $639.99 million.
Orthofix Medical Inc ended 2024 with $0 in deferred long-term liabilities, $141.80 million in other current liabilities, 3673000.00 in common stock, $-99113000.00 in retained earnings and $191.73 million in goodwill. Its cash balance stood at $37.61 million and cash and short-term investments were $37.61 million. The company’s total short-term debt was $3,837,000 while long-term debt stood at $51.00 million.
Orthofix Medical Inc’s total current assets stands at $399.35 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $112.32 million compared to accounts payable of $51.35 million and inventory worth $222.47 million.
In 2024, Orthofix Medical Inc's operating cash flow was $0 while its capital expenditure stood at $12.82 million.
Comparatively, Orthofix Medical Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $13.01
- 52-Week High
- $23.19
- 52-Week Low
- $12.93
- Analyst Target Price
- $35.5
Orthofix Medical Inc stock is currently trading at $13.01 per share. It touched a 52-week high of $23.19 and a 52-week low of $23.19. Analysts tracking the stock have a 12-month average target price of $35.5.
Its 50-day moving average was $19.33 and 200-day moving average was $19.23 The short ratio stood at 3.2 indicating a short percent outstanding of 0%.
Around 237.3% of the company’s stock are held by insiders while 9047.2% are held by institutions.
Frequently Asked Questions About Orthofix Medical Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Orthofix Medical Inc. operates spine and orthopedics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through Global Spine and Global Orthopedics segments. The Global Spine segment comprises the bone growth therapies products, which manufactures and distributes bone growth stimulator devices for enhance of bone fusion including adjunctive and noninvasive treatment of cervical and lumbar spine as well as a therapeutic treatment for non-spine; the spinal implants products designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and the biological products, such as regenerative products and tissue forms which allow physicians to treat a variety of spinal and orthopedic conditions. Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions unrelated to the spine, which design, develop, and market the orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. It sells its products through distributors, sales representatives, hospitals, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.